SCHEMBL6208517

SCHEMBL6208517

CC(CC(N)=O)CC(=O)N1CCC2C1C(=O)CN2S(=O)(=O)c1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.39
HCRTR2 O43614 1/20 0.38
HPGD P15428 1/20 0.37
ELOVL6 Q9H5J4 1/20 0.37
TSHR P16473 1/20 0.36
SMYD3 Q9H7B4 1/20 0.36
GAA P10253 1/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
USP2 O75604 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6209144 0.87 SMYD3 (0.38) TSHRSMYD3ALDH1A1
SCHEMBL6209880 0.87 PREP (0.35) GAAALDH1A1
SCHEMBL6208880 0.85 KDM4E (0.42) HSD17B10KDM4EHPGDTSHRSMYD3
SCHEMBL6208666 0.84 KDM4E (0.39) HSD17B10KDM4EHCRTR2HPGDTSHR
SCHEMBL6210484 0.83 CTSL (0.39) ELOVL6
SCHEMBL6211558 0.83 LMNA (0.38) HSD17B10HCRTR2ELOVL6TSHRSMYD3
SCHEMBL4039220 0.82 HSD17B10 (0.42) HSD17B10KDM4EHCRTR2HPGDELOVL6
SCHEMBL6213622 0.82 LMNA (0.38) HSD17B10ELOVL6TSHRSMYD3POLB
SCHEMBL6208825 0.81 PAX8 (0.40) KDM4EPOLBALDH1A1
SCHEMBL6212436 0.81 LMNA (0.38) HSD17B10HCRTR2ELOVL6TSHRSMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed